Skip to content

Efficacy of Balanced Cupping Combined with Herbal Fumigation for Diabetic Peripheral Neuropathy (Phlegm-Stasis Obstructing Collaterals Pattern): A Randomized Controlled Trial

Clinical Efficacy Observation of Chinese Medicine Fumigation Combined with Balance Can Therapy in the Treatment of Diabetic Peripheral Neuropathy Based on Gasification Theory Application

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002601
Enrollment
Unknown
Registered
2025-12-30
Start date
2024-06-06
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experimental Group 1:Conventional diet and exercise group, Western medicine group, and Chinese medicine fumigation therapy group
Experimental Group 2:Conventional diet and exercise group, Western medicine group, Chinese medicine fumigation combined with balance tank therapy group

Sponsors

Ningbo Municipal Hospital of Traditional Chinese Medicine ,Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age over 18 years old; under 75 years old 2) Meet the diagnostic criteria for diabetes mellitus; 3) Meet the diagnostic criteria for diabetic peripheral neuropathy; 4) No use of external therapies such as Chinese herbal steam therapy or cupping on the upper and lower limbs within 3 months to relieve symptoms of peripheral neuropathy; 5) Able to accept steam therapy and balancing cupping therapy, with good patient compliance and signed informed consent form.

Exclusion criteria

Exclusion criteria: 1) Pregnant women or lactating women; 2) Those with acute diabetic complications such as diabetic ketoacidosis, ketosis acidosis, and severe infections within the past half month; 3) Patients with severe primary diseases of the liver, heart, kidney, brain, blood system, and mental illness; 4) Those who are alcoholics and/or have drug abuse and dependence; 5) Those with incomplete skin or allergic constitution, such as those allergic to any components of this prescription; 6) Those with peripheral neuropathy caused by other reasons; those with severe cardiovascular and cerebrovascular diseases; those with acute diabetic complications (such as hyperosmolar diabetic coma, diabetic ketoacidosis, etc.); those with mental illnesses who cannot cooperate with treatment; and those currently receiving relevant treatment. 7) Other causes of neuropathy need to be excluded, such as cervical and lumbar spine lesions (nerve root compression, spinal stenosis, degenerative changes of cervical and lumbar spine), cerebral infarction, Guillain-Barré syndrome, severe arteriovenous vascular lesions (venous thrombosis, lymphangitis), etc. It is also necessary to differentiate neuropathy caused by drugs, especially chemotherapy drugs.

Design outcomes

Primary

MeasureTime frame
Metabolic indicators include: fasting blood glucose (FBG), conduction velocity of the tibial nerve and peroneal nerve, Toronto Clinical Score, 2-hour postprandial blood glucose (2hPG), and glycated hemoglobin;Efficacy indicators: The Toronto Clinical Rating Scale was used;

Countries

china

Contacts

Public ContactQiudan Jiang

Ningbo Municipal Hospital of Traditional Chinese Medicine ,Affiliated to Zhejiang Chinese Medical University

364277725@qq.com13656886347

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026